Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 7585515.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this study we examined loss of heterozygosity (LOH) on chromosome 13q12-13 in 50 tumors from BRCA2 carriers in five families showing strong evidence of linkage to BRCA2. In addition to high frequency of LOH in female breast cancer, LOH was observed in tumors of the prostate, ovary, cervix, colon, male breast, and ureter. All detected losses involved the wild-type chromosome. These results suggest that BRCA2 is a tumor suppressor gene and may be involved in the tumorigenesis of several cancer types in addition to breast cancer.
Medical subject headings
- Breast Neoplasms
- Chromosome Deletion
- Chromosomes, Human, Pair 13
- Neoplasm Proteins
- Neoplasms
- Transcription Factors